---
created: '2026-02-13T14:57:56.892896Z'
description: Alpha-Fetoprotein (AFP) test. Tumor marker used for hepatocellular carcinoma
  surveillance in high-risk patients and monitoring of testicular germ cell tumors.
  Also used in prenatal screening for neural tube defects.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/labtest/afp/
slug: afp
tags:
- labtest
templateEngineOverride: njk
title: afp
type: labtest
updated: '2026-02-13T14:57:56.892896Z'
---

{% raw %}
<h1>AFP</h1>
<h2>Overview</h2>
<p>Alpha-Fetoprotein (AFP) is a major plasma protein produced by the fetal liver and yolk sac during embryonic development. In healthy adults, AFP levels are normally very low (&lt;10 ng/mL). Elevated AFP levels in non-pregnant adults are primarily associated with hepatocellular carcinoma (HCC), certain germ cell tumors (particularly nonseminomatous testicular cancer and yolk sac tumors), and chronic liver disease including cirrhosis and hepatitis.</p>
<p>In hepatology, AFP is used as a surveillance biomarker for hepatocellular carcinoma in high-risk populations, particularly patients with cirrhosis or chronic hepatitis B/C infection. The American Association for the Study of Liver Diseases (AASLD) recommends abdominal ultrasound with or without AFP every 6 months for HCC surveillance. While AFP alone has limited sensitivity (approximately 60% at the 20 ng/mL cutoff), it complements ultrasound imaging for improved detection.</p>
<p>In oncology, AFP is a key component of the International Germ Cell Cancer Collaborative Group (IGCCCG) staging system for testicular cancer. AFP levels, along with beta-hCG and LDH, determine risk classification and guide treatment intensity. AFP has a half-life of approximately 5-7 days, and post-treatment kinetics are monitored to assess treatment adequacy and detect recurrence.</p>
<p><strong>Evidence Level:</strong> ⭐⭐⭐ (3/5)</p>
<h2>Test Information</h2>
<table>
<thead>
<tr>
<th>Property</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Category</strong></td>
<td>Cancer Screening</td>
</tr>
<tr>
<td><strong>Test Type</strong></td>
<td>Specialized</td>
</tr>
<tr>
<td><strong>Sample Type</strong></td>
<td>Blood</td>
</tr>
<tr>
<td><strong>Collection Method</strong></td>
<td>Venipuncture</td>
</tr>
<tr>
<td><strong>Fasting Required</strong></td>
<td>No</td>
</tr>
<tr>
<td><strong>HSA Eligible</strong></td>
<td>Yes</td>
</tr>
<tr>
<td><strong>FSA Eligible</strong></td>
<td>Yes</td>
</tr>
</tbody>
</table>
<h2>Reference Ranges</h2>
<table>
<thead>
<tr>
<th>Range</th>
<th>Value</th>
<th>Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Normal</strong></td>
<td>&lt;10 ng/mL</td>
<td>Within normal limits for non-pregnant adults</td>
</tr>
<tr>
<td><strong>Mildly Elevated</strong></td>
<td>10-20 ng/mL</td>
<td>May indicate chronic liver disease; monitor trend</td>
</tr>
<tr>
<td><strong>Elevated</strong></td>
<td>20-200 ng/mL</td>
<td>Suspicious for HCC or germ cell tumor; imaging recommended</td>
</tr>
<tr>
<td><strong>Markedly Elevated</strong></td>
<td>&gt;200 ng/mL</td>
<td>Highly suggestive of HCC or germ cell malignancy</td>
</tr>
<tr>
<td><strong>Diagnostic for HCC</strong></td>
<td>&gt;400 ng/mL</td>
<td>Virtually diagnostic for HCC in cirrhotic patient</td>
</tr>
</tbody>
</table>
<h2>Recommended For</h2>
<h3>Conditions</h3>
<p>Useful for monitoring or diagnosing:</p>
<ul>
<li><a class="internal-link is-unresolved" href="/404">Hepatocellular Carcinoma</a></li>
<li><a class="internal-link is-unresolved" href="/404">Testicular Cancer</a></li>
<li><a class="internal-link is-unresolved" href="/404">Cirrhosis</a></li>
<li><a class="internal-link is-unresolved" href="/404">Chronic Hepatitis B</a></li>
<li><a class="internal-link is-unresolved" href="/404">Chronic Hepatitis C</a></li>
</ul>
<h2>Relationships</h2>
<h3>Measures</h3>
<ul>
<li>→ <a href="/garden/dev_admin/labtest/afp/" class="internal-link">AFP</a> (biomarker)</li>
</ul>
<h3>Included In</h3>
<ul>
<li>→ <a href="/garden/dev_admin/labtestpanel/cancer-screening-panel/" class="internal-link">cancer screening panel</a> (labtestpanel)</li>
</ul>
<h2>Notes</h2>
<ul>
<li>Results should be interpreted by a qualified healthcare provider</li>
<li>Reference ranges may vary by laboratory</li>
<li>AFP surveillance every 6 months is recommended for patients with cirrhosis</li>
<li>AFP-L3 (lens culinaris agglutinin-reactive AFP fraction) improves specificity for HCC</li>
<li>AFP half-life is 5-7 days; post-treatment kinetics guide ongoing management</li>
<li>Pregnancy causes physiologically elevated AFP (peaks in third trimester)</li>
<li>Chronic hepatitis and cirrhosis can cause mild AFP elevations without malignancy</li>
</ul>
<hr />
<p><em>Last Updated: 2026-02-07</em></p>

{% endraw %}